Literature DB >> 32972751

Metabolic regulation of EGFR effector and feedback signaling in pancreatic cancer cells requires K-Ras.

Szu-Wei Lee1, Cosimo Commisso2.   

Abstract

Nutrient stress driven by glutamine deficiency activates EGFR signaling in a subset of KRAS-mutant pancreatic ductal adenocarcinoma (PDAC) cells. EGFR signaling in the context of glutamine starvation is thought to be instigated by the transcriptional upregulation of EGFR ligands and functions as an adaptation mechanism to allow PDAC cells to maintain metabolic fitness. Having a clear view of the intricate signaling cascades potentiated by the metabolic induction of EGFR is important in understanding how these effector pathways influence cancer progression. In this study, we examined the complex signaling that occurs in PDAC cells when EGFR is activated by glutamine deprivation. We elucidate that the metabolic activation of EGFR is principally mediated by HB-EGF, and that other members of the ErbB receptor tyrosine kinase family are not activated by glutamine starvation. Additionally, we determine that glutamine depletion-driven EGFR signaling is associated with a specific receptor phosphorylation known to participate in a feedback loop, a process that is dependent on Erk. Lastly, we determine that K-Ras is required for glutamine depletion-induced Erk activation, as well as EGFR feedback phosphorylation, but is dispensable for Akt activation. These data provide important insights into the regulation of EGFR signaling in the context of metabolic stresses.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Akt; EGFR; Erk; Glutamine; Metabolism; Nutrient stress; Ras

Year:  2020        PMID: 32972751      PMCID: PMC7655618          DOI: 10.1016/j.bbrc.2020.09.029

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

1.  Human pancreatic cancer tumors are nutrient poor and tumor cells actively scavenge extracellular protein.

Authors:  Jurre J Kamphorst; Michel Nofal; Cosimo Commisso; Sean R Hackett; Wenyun Lu; Elda Grabocka; Matthew G Vander Heiden; George Miller; Jeffrey A Drebin; Dafna Bar-Sagi; Craig B Thompson; Joshua D Rabinowitz
Journal:  Cancer Res       Date:  2015-02-01       Impact factor: 12.701

2.  Specificity and mechanism of action of some commonly used protein kinase inhibitors.

Authors:  S P Davies; H Reddy; M Caivano; P Cohen
Journal:  Biochem J       Date:  2000-10-01       Impact factor: 3.857

3.  EGF receptor is required for KRAS-induced pancreatic tumorigenesis.

Authors:  Christine M Ardito; Barbara M Grüner; Kenneth K Takeuchi; Clara Lubeseder-Martellato; Nicole Teichmann; Pawel K Mazur; Kathleen E Delgiorno; Eileen S Carpenter; Christopher J Halbrook; Jason C Hall; Debjani Pal; Thomas Briel; Alexander Herner; Marija Trajkovic-Arsic; Bence Sipos; Geou-Yarh Liou; Peter Storz; Nicole R Murray; David W Threadgill; Maria Sibilia; M Kay Washington; Carole L Wilson; Roland M Schmid; Elaine W Raines; Howard C Crawford; Jens T Siveke
Journal:  Cancer Cell       Date:  2012-09-11       Impact factor: 31.743

4.  EGF receptor signaling is essential for k-ras oncogene-driven pancreatic ductal adenocarcinoma.

Authors:  Carolina Navas; Isabel Hernández-Porras; Alberto J Schuhmacher; Maria Sibilia; Carmen Guerra; Mariano Barbacid
Journal:  Cancer Cell       Date:  2012-09-11       Impact factor: 31.743

5.  EGFR-Pak Signaling Selectively Regulates Glutamine Deprivation-Induced Macropinocytosis.

Authors:  Szu-Wei Lee; Yijuan Zhang; Michael Jung; Nathalia Cruz; Basheer Alas; Cosimo Commisso
Journal:  Dev Cell       Date:  2019-06-27       Impact factor: 12.270

6.  ERK-dependent threonine phosphorylation of EGF receptor modulates receptor downregulation and signaling.

Authors:  Xin Li; Yao Huang; Jing Jiang; Stuart J Frank
Journal:  Cell Signal       Date:  2008-08-15       Impact factor: 4.315

7.  Epidermal growth factor and membrane trafficking. EGF receptor activation of endocytosis requires Rab5a.

Authors:  M A Barbieri; R L Roberts; A Gumusboga; H Highfield; C Alvarez-Dominguez; A Wells; P D Stahl
Journal:  J Cell Biol       Date:  2000-10-30       Impact factor: 10.539

8.  Inhibition of Receptor Dimerization as a Novel Negative Feedback Mechanism of EGFR Signaling.

Authors:  Malgorzata Kluba; Yves Engelborghs; Johan Hofkens; Hideaki Mizuno
Journal:  PLoS One       Date:  2015-10-14       Impact factor: 3.240

9.  KRAS above and beyond - EGFR in pancreatic cancer.

Authors:  Jens T Siveke; Howard C Crawford
Journal:  Oncotarget       Date:  2012-11

10.  Macropinocytosis of protein is an amino acid supply route in Ras-transformed cells.

Authors:  Cosimo Commisso; Shawn M Davidson; Rengin G Soydaner-Azeloglu; Seth J Parker; Jurre J Kamphorst; Sean Hackett; Elda Grabocka; Michel Nofal; Jeffrey A Drebin; Craig B Thompson; Joshua D Rabinowitz; Christian M Metallo; Matthew G Vander Heiden; Dafna Bar-Sagi
Journal:  Nature       Date:  2013-05-12       Impact factor: 49.962

  10 in total
  1 in total

Review 1.  KRASG12R-Independent Macropinocytosis in Pancreatic Cancer.

Authors:  G Aaron Hobbs; Channing J Der
Journal:  Subcell Biochem       Date:  2022
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.